Bill Taaffe has been appointed chief executive officer of WCCT Global, an international specialized CRO.   Mr. Taaffe has served on WCCT’s board of directors since 2012 and has also served as president of Medelis, a specialty oncology CRO which merged with WCCT in May of 2016. Prior to joining WCCT’s board, Mr. Taaffe was one of the founding members of ICON plc. He joined ICON’s U.S. clinical operations in 1993 and oversaw its growth from nine employees to more than 4,500 emp...